Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.67
-0.20 (-1.80%)
At close: Jun 26, 2026, 4:00 PM EDT
10.66
0.00 (-0.05%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Telix Pharmaceuticals Employees
As of December 31, 2025, Telix Pharmaceuticals had 1,184 total employees, including 1,120 full-time and 64 part-time employees. The number of employees increased by 950 or 405.98% compared to the previous year.
Employees
1,184
Change
950
Growth
405.98%
Revenue / Employee
$678,880
Profits / Employee
-$6,018
Market Cap
3.59B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,184 | 950 | 405.98% |
| Dec 31, 2022 | 234 | 76 | 48.10% |
| Dec 31, 2021 | 158 | 149 | 1,655.56% |
| Dec 31, 2017 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Beam Therapeutics | 522 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Relay Therapeutics | 193 |
TLX News
- 4 days ago - Telix Pharmaceuticals Rises 2.5% as Stock Continues Rebound From Three-Year Low - International Business Times (Australia)
- 4 days ago - Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions - GlobeNewsWire
- 23 days ago - Telix Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 24 days ago - Telix Pharmaceuticals Transcript: 46th Annual William Blair Growth Stock Conference - Transcripts
- 24 days ago - Telix Pharmaceuticals Slides: 46th Annual William Blair Growth Stock Conference - Filings
- 25 days ago - Telix and United Imaging Announce Strategic Theranostics Collaboration - GlobeNewsWire
- 25 days ago - ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026 - GlobeNewsWire
- 4 weeks ago - Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences - GlobeNewsWire